Tag: Verona Pharma

April 18, 2017 Off

FDA nods for Verona’s inhibitor trial

By Dino Mustafić

Respiratory diseases biopharmaceutical specialist, Verona Pharma said Tuesday that the U.S. Food and Drug Administration has given the green light for the kick-start of a pharmacokinetic (PK) clinical trial in the U.S. for its RPL554 candidate, with the acceptance of an Investigational New Drug application (IND).